Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells
TIMP2 levels in tumour microenvironment may have prognostic value in patients with PDAC.
»
12/13/19
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
Upregulation of hnRNPK activates expression of splicing regulator SRSF1.
»
12/12/19
Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University
Distant metastasis was most common cause of death.
»
12/12/19
The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis
Regulation of Spy1 by p53 is at protein level.
»
12/11/19
Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
Age and comorbidity independent factors for non-cancer mortality.
»
12/21/19
Non-destructive, label free identification of cell cycle phase in cancer cells by multispectral microscopy of autofluorescence
Redox ratio and ratio of protein bound to free NADH significantly affected.
»
12/21/19
Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer
miR-101-3p also downregulated IL6ST, STAT3A/B, and MYC mRNA levels.
»
12/21/19
The prognostic capacities of CBP and p300 in locally advanced rectal cancer
High expression of CBP significantly associated with prolonged cancer-specific survival.
»
12/19/19
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
Mortaparib as first dual inhibitor of mortalin and PARP1.
»
12/19/19
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
Combined analysis of CTCs and cfDNA more informative than combination of two conventional biomarkers.
»
12/19/19
< Prev
Next >